Ann: Race releases complete cardio-protection data & video, page-136

First 136 Last

Share
Profile

Follow
Boffin99

2,885 Posts.

2909

06/05/23

14:05

Post #: 67639783
Share

Originally posted by Boffin99: ↑

Cardio Protection and Anti-Cancer;

My view on the Mechanism of Action of what is going on;

1. Bisantrene is a magnet to iron.

2. Cardiotoxicity is caused by iron dependent functions such as oxidative stress and ROS production.

3. By binding tightly to iron, Bisantrene reduces the iron that feeds Cardiotoxicity.

4. Basically, Bisantrene is the ‘Cookie Monster’ and iron is the ‘Cookie’. Without the cookie there is no cardiotoxicity.

5. But Oxidative stress can help kill cancer so reducing this can reduce anti-cancer effects.

6. Some good news, healthy cells counteract oxidative stress at a superior rates to cancer cells.

7. Whilst Oxidative stress is sufficiently reduced for healthy cells to be protected, cancer cells remain unprotected.

8. Bisantrene therefore hits the sweet spot where it retains cardio protection and anti-cancer effects.

9. At high doses Bisantrene acts relies on its Anthracycline effects to kill cancer.

10. At low doses Bisantrene is relies on its super power as an FTO inhibitor (binding to the catalytic pocket of FTO).

11. FTO overexpression correlates to the growth of 30+ cancers and also linked to drug resistance.

12. Reducing FTO expression can stop the growth of cancer and helps kill treatment resistance tumours.

13. Bisantrene is additive and synergenistic with other standard of care treatments.

There is definitely a lot of luck involved with Bisantrene. Starting off as a legacy chemo drug for AML. Now extending to a potential platform drug as the worlds first FTO inhibitor in the clinic and cardio-protective anti-cancer solution.

#Disrupting Cardio-oncology 2023

Expand

We are expecting an update from Dr Jensen this quarter. If to do with redox cycling / iron metabolism should be towards the higher end of the triangle report.

RAC Price at posting: $1.85 Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

What's causing the cost-of-living crisis, and how to navigate it

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint